News

2019

04.13.19

Casma Therapeutics Named one of the Boston Business Journal’s Best Places to Work

READ MORE

03.26.19

Casma Therapeutics Establishes Scientific Advisory Board with Appointments of Leading Autophagy and Neuroscience Researchers

READ MORE

2018

12.12.18

Casma Therapeutics Strengthens Leadership Team with Appointment of Chief Operating Officer, Vice President of People & Culture

READ MORE

12.06.18

Casma Therapeutics Licenses Technology to Advance Autophagy-Based Drug Discovery

READ MORE

09.11.18

Casma Therapeutics Announces Partnership with Fondazione Telethon, Founder of the Telethon Institute of Genetics and Medicine (TIGEM)

READ MORE

08.06.18

Casma Therapeutics Expands Executive Team with Appointment of Two Senior Vice Presidents

READ MORE

05.30.18

Casma Therapeutics Co-Founder Reports Health Benefits of Increased Autophagy in Mammals in Nature Publication

READ MORE

05.03.18

Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies

READ MORE

Social Media

@CasmaTx

We're delighted to be one of @BosBizJournal's Best Places to Work for 2019! We’re proud of our company, our culture…

@CasmaTx

We’re very excited to establish our scientific advisory board with the appointments of Sascha Martens, Ph.D., and P…